Prognostic value of serum levels of soluble MICA (sMICA) in patients with prostate cancer

Br J Biomed Sci. 2018 Apr;75(2):98-100. doi: 10.1080/09674845.2017.1402405. Epub 2018 Mar 7.

Authors

Y Liu^{1

2}, X Guo², M Xing^{1

3}, K Zhao², L Luo⁴, J Du^{1

3}

Affiliations

¹ a Department of Urology , Qilu Hospital of Shandong University , Jinan , China.
² b Department of Reproductive Medicine , The Affiliated Hospital of Qingdao University , Qingdao , China.
³ c Department of Clinical Laboratory , Yuhuangding Hospital of Yantai , Yantai , China.
⁴ d Department of Urology , The Affiliated Hospital of Qingdao University , Qingdao , China.

PMID: 29513160
DOI: 10.1080/09674845.2017.1402405

No abstract available

Keywords: Prostate cancer; prognosis; soluble MICA.

MeSH terms

Aged
Aged, 80 and over
Biomarkers, Tumor / blood*
Histocompatibility Antigens Class I / blood*
Humans
Male
Middle Aged
Predictive Value of Tests
Prognosis*
Prostatic Neoplasms / blood*
Prostatic Neoplasms / pathology

Substances

Biomarkers, Tumor
Histocompatibility Antigens Class I
MHC class I-related chain A